Company / Current Assets per Share
Idexx Laboratories Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$17.33
FY2025
5-year range
$11.18 / $18.04
FY2021-FY2025
Trend
+2.8%
vs FY2024
Sector context
#67 of 163
Health Care
What the data says
At $17.33, Idexx Laboratories's current assets per share ranks #67 of 163 in the Health Care sector. Current Assets per Share has fluctuated over the past 10 years, ranging from $7.51 in FY2018 to $18.04 in FY2023.
Based on SEC 10-K filings.
17.33 in FY2025 with a 5-year CAGR of +6.9%.
Declined from $18.04 to $17.33 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +10.0%
- 5-Year CAGR
- +6.9%
- 10-Year CAGR
- -
Sector benchmark
#67 of 163 in Health CareTop 41% of 163This company $17.33 Sector average $52.97
▼
-67.3% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 2.8% year-over-year.
- Ranks #67 out of 163 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2023.
- Lowest current assets per share in the period was in FY2018.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.33 | +2.8% |
| FY2024 | $16.86 | -6.5% |
| FY2023 | $18.04 | +38.5% |
| FY2022 | $13.03 | +16.5% |
| FY2021 | $11.18 | -10.1% |
| FY2020 | $12.43 | +57.5% |
| FY2019 | $7.89 | +5.1% |
| FY2018 | $7.51 | -27.6% |
| FY2017 | $10.38 | +24.6% |
| FY2016 | $8.33 | +9.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026